Aluminum Hydroxide Adjuvanted Multi-epitope SARS-CoV-2 Vaccine

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A vaccine composed of chemically synthesized peptides of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epitopes, conjugated to a recombinant carrier protein, and adsorbed on aluminum hydroxide, with potential immunomodulating and anti-COVID-19 activities. Upon administration of aluminum hydroxide adjuvanted multi-epitope SARS-CoV-2 vaccine, the SARS-CoV-2 peptides activate the immune system to produce antibodies and T-cell responses against these SARS-CoV-2 peptides. This kills SARS-CoV-2 and prevents SARS-CoV-2 infection. The aluminum hydroxide adjuvant improves antigen processing by the immune system.

**Synonyms:** - EpiVacCorona